{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:25:44Z","timestamp":1778689544363,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-424","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T17:06:23Z","timestamp":1402592783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Wei","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,12]]},"reference":[{"key":"4656_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90.","journal-title":"CA Cancer J Clin"},{"key":"4656_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics. CA Cancer J Clin. 2012, 62: 10-29.","journal-title":"CA Cancer J Clin"},{"key":"4656_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1586\/era.11.24","volume":"11","author":"T Onda","year":"2011","unstructured":"Onda T, Yoshikawa H: Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions. Expert Rev Anticancer Ther. 2011, 11: 1053-1067.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4656_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","volume":"198","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IM: Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol. 2008, 198: 351-356.","journal-title":"Am J Obstet Gynecol"},{"key":"4656_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(91)90428-2","volume":"66","author":"Y Ben-David","year":"1991","unstructured":"Ben-David Y, Bernstein A: Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 1991, 66: 831-834.","journal-title":"Cell"},{"key":"4656_CR6","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1016\/S0021-9258(18)53385-8","volume":"268","author":"MJ Klemsz","year":"1994","unstructured":"Klemsz MJ, Maki RA, Moore J, Hromas R: Characterization of the ets oncogene family member, fli-1. J Biol Chem. 1994, 268: 5769-5773.","journal-title":"J Biol Chem"},{"key":"4656_CR7","doi-asserted-by":"publisher","first-page":"6432","DOI":"10.1038\/sj.onc.1204039","volume":"19","author":"IG Maroulakou","year":"2000","unstructured":"Maroulakou IG, Bowe DB: Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene. 2000, 19: 6432-6442.","journal-title":"Oncogene"},{"key":"4656_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","volume":"303","author":"T Oikawa","year":"2003","unstructured":"Oikawa T, Yamada T: Molecular biology of the Ets family of transcription factors. Gene. 2003, 303: 11-34.","journal-title":"Gene"},{"key":"4656_CR9","first-page":"551","volume":"7","author":"B Davidson","year":"2001","unstructured":"Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM: Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res. 2001, 7: 551-557.","journal-title":"Clin Cancer Res"},{"key":"4656_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1349-7006.2004.tb03320.x","volume":"95","author":"T Oikawa","year":"2004","unstructured":"Oikawa T: ETS transcription factors: possible targets for cancer therapy. Cancer Sci. 2004, 95: 626-633.","journal-title":"Cancer Sci"},{"key":"4656_CR11","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1128\/MCB.16.6.2708","volume":"16","author":"F Melet","year":"1996","unstructured":"Melet F, Motro B, Rossi DJ, Zhang L, Bernstein A: Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol Cell Biol. 1996, 16: 2708-2718.","journal-title":"Mol Cell Biol"},{"key":"4656_CR12","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1038\/sj.onc.1204042","volume":"19","author":"AH Truong","year":"2000","unstructured":"Truong AH, Ben-David Y: The role of Fli-1 in normal cell function and malignant transformation. Oncogene. 2000, 19: 6482-6489.","journal-title":"Oncogene"},{"key":"4656_CR13","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","volume":"20","author":"DD Spyropoulos","year":"2000","unstructured":"Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK: Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol. 2000, 20: 5643-5652.","journal-title":"Mol Cell Biol"},{"key":"4656_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cub.2008.07.048","volume":"18","author":"F Liu","year":"2008","unstructured":"Liu F, Walmsley M, Rodaway A, Patient R: Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol. 2008, 18: 1234-1240.","journal-title":"Curr Biol"},{"key":"4656_CR15","first-page":"6428","volume":"11","author":"GK Lakhanpal","year":"2010","unstructured":"Lakhanpal GK, Vecchiarelli-Federico LM, Li YJ, Cui JW, Bailey ML, Spaner DE, Dumont DJ, Barber DL, Ben-David Y: The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood. 2010, 11: 6428-6436.","journal-title":"Blood"},{"key":"4656_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/leu.2009.20","volume":"23","author":"JW Cui","year":"2009","unstructured":"Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y: Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia. 2009, 23: 1311-1319.","journal-title":"Leukemia"},{"key":"4656_CR17","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-09-2261","volume":"16","author":"HV Erkizan","year":"2010","unstructured":"Erkizan HV, Uversky VN, Toretsky JA: Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing\u2019s sarcoma. Clin Cancer Res. 2010, 16: 4077-4083.","journal-title":"Clin Cancer Res"},{"key":"4656_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.25564","volume":"128","author":"I Takigami","year":"2011","unstructured":"Takigami I, Ohno T, Kitade Y, Hara A, Nagano1 A, Kawai G, Saitou M, Matsuhashi A, Yamada K, Shimizu K: Synthetic siRNA targeting the breakpoint of EWS\/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model. Int J Cancer. 2011, 128: 216-226.","journal-title":"Int J Cancer"},{"key":"4656_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/cncr.25522","volume":"117","author":"JJ Zhang","year":"2011","unstructured":"Zhang JJ, Guo HY, Zhang H, Wang HB, Qian GX XF, Hoffman AR, Hu JF, Ge S: Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1. Cancer. 2011, 117: 86-95.","journal-title":"Cancer"},{"key":"4656_CR20","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1128\/MCB.19.6.4452","volume":"19","author":"A Tamir","year":"1999","unstructured":"Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben-David Y: Fli-1, an Ets-related transcription factor, regulates erythropoietin- induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol. 1999, 19: 4452-4464.","journal-title":"Mol Cell Biol"},{"key":"4656_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/sj.onc.1201099","volume":"14","author":"H Yi","year":"1997","unstructured":"Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES: Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene. 1997, 14: 1259-1268.","journal-title":"Oncogene"},{"key":"4656_CR22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/sj.onc.1202534","volume":"18","author":"R Pereira","year":"1999","unstructured":"Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J: FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene. 1999, 18: 1597-1608.","journal-title":"Oncogene"},{"key":"4656_CR23","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/bcj.2011.52","volume":"2","author":"YJ Li","year":"2012","unstructured":"Li YJ, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, Ben-David Y: Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Canc J. 2012, 2: e54-","journal-title":"Blood Canc J"},{"key":"4656_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009, 59: 225-249.","journal-title":"CA Cancer J Clin"},{"key":"4656_CR25","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z","volume":"89","author":"BA Goff","year":"2000","unstructured":"Goff BA, Mandel L, Muntz HG, Melancon CH: Ovarian carcinoma diagnosis. Cancer. 2000, 89: 2068-2075.","journal-title":"Cancer"},{"key":"4656_CR26","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1525-1438.2005.15351.x","volume":"15","author":"RF Ozols","year":"2005","unstructured":"Ozols RF: Treatment goals in ovarian cancer. Int J Gynecol Cancer. 2005, 15: S3-S11.","journal-title":"Int J Gynecol Cancer"},{"key":"4656_CR27","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.3390\/ijms14046571","volume":"14","author":"M Kessler","year":"2013","unstructured":"Kessler M, Fotopoulou C, Meyer T: The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin. Int J Mol Sci. 2013, 14: 6571-6596.","journal-title":"Int J Mol Sci"},{"key":"4656_CR28","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"26","author":"K Levanon","year":"2008","unstructured":"Levanon K, Crum C, Drapkin R: Newinsights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol. 2008, 26: 5284-5293.","journal-title":"J Clin Oncol"},{"key":"4656_CR29","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/art.30284","volume":"63","author":"AM Bujor","year":"2011","unstructured":"Bujor AM, Asano Y, Haines P, Lafyatis R, Trojanowska M: The C-ABL tyrosine kinase controls PKC\u03b4 induced Fli1 phosphorylation in human dermal fibroblasts. Arthritis Rheum. 2011, 63: 1729-1737.","journal-title":"Arthritis Rheum"},{"key":"4656_CR30","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1128\/MCB.23.10.3427-3441.2003","volume":"23","author":"M Eisbacher","year":"2003","unstructured":"Eisbacher M, Holmes ML, Newton A, Hogg PJ, Khachigian LM, Crossley M, Chong BH: Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol Cell Biol. 2003, 23: 3427-3441.","journal-title":"Mol Cell Biol"},{"key":"4656_CR31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/MCB.23.4.1390-1402.2003","volume":"23","author":"J Starck","year":"2003","unstructured":"Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, Doubeikovski A, Verger A, Duterque-Coquillaud M, Morle F: Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol. 2003, 23: 1390-1402.","journal-title":"Mol Cell Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-424\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:46:17Z","timestamp":1630557977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4656"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-424","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,12]]},"assertion":[{"value":"21 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"424"}}